Do Cao C - Search Results

1

[Malignant insulinoma: recommendations for workup and treatment].

Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C; pour la Société française d’endocrinologie et le Groupe d’étude des tumeurs endocrines. Baudin E, et al. Among authors: do cao c. Presse Med. 2014 Jun;43(6 Pt 1):645-59. doi: 10.1016/j.lpm.2013.08.007. Epub 2014 May 21. Presse Med. 2014. PMID: 24857257 French.

2

[Exploration and management of thyroid nodules].

Benderradji H, Do Cao C, Ladsous M, Wémeau JL. Benderradji H, et al. Among authors: do cao c. Rev Prat. 2023 Apr;73(4):431-437. Rev Prat. 2023. PMID: 37289163 French.

3

Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma.

Chevalier B, Karleskind O, Jannin A, Farchi O, Vermaut C, Escande A, Baillet C, Espiard S, Vantyghem MC, Carnaille B, Leteurtre E, Do Cao C. Chevalier B, et al. Among authors: do cao c. Eur Thyroid J. 2022 Dec 22;12(1):e220111. doi: 10.1530/ETJ-22-0111. Print 2023 Feb 1. Eur Thyroid J. 2022. PMID: 36377723 Free PMC article.

4

Proteinuria reduction with SGLT2 inhibitors in a patient treated with tyrosine kinase inhibitor lenvatinib.

Fages V, Jannin A, Maanaoui M, Glowacki F, Do Cao C. Fages V, et al. Among authors: do cao c. J Nephrol. 2024 Jan;37(1):187-189. doi: 10.1007/s40620-023-01701-0. Epub 2023 Jul 7. J Nephrol. 2024. PMID: 37418091

5

Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma.

Baudin E, Docao C, Gicquel C, Vassal G, Bachelot A, Penfornis A, Schlumberger M. Baudin E, et al. Ann Oncol. 2002 Nov;13(11):1806-9. doi: 10.1093/annonc/mdf291. Ann Oncol. 2002. PMID: 12419755 Free article. Clinical Trial.

6

Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.

Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M. Baudin E, et al. Among authors: do cao c. J Clin Endocrinol Metab. 2003 Mar;88(3):1107-11. doi: 10.1210/jc.2002-021365. J Clin Endocrinol Metab. 2003. PMID: 12629092

7

A score based on microscopic criteria proposed for analysis of papillary carcinoma of the thyroid.

Verhulst P, Devos P, Aubert S, Buob D, Cranshaw I, Do Cao C, Pattou F, Carnaille B, Wemeau JL, Leteurtre E. Verhulst P, et al. Among authors: do cao c. Virchows Arch. 2008 Mar;452(3):233-40. doi: 10.1007/s00428-008-0577-x. Virchows Arch. 2008. PMID: 18239937

8

Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation?

Pigny P, Cardot-Bauters C, Do Cao C, Vantyghem MC, Carnaille B, Pattou F, Caron P, Wemeau JL, Porchet N. Pigny P, et al. Among authors: do cao c. Eur J Endocrinol. 2009 Feb;160(2):227-31. doi: 10.1530/EJE-08-0574. Epub 2008 Nov 24. Eur J Endocrinol. 2009. PMID: 19029228

9

[Current management of thyroid malignancies].

Do Cao C, Wémeau JL. Do Cao C, et al. Presse Med. 2009 Feb;38(2):210-9. doi: 10.1016/j.lpm.2008.05.018. Epub 2009 Jan 14. Presse Med. 2009. PMID: 19147329 French.

10

Chromogranin A assay in clinical practice.

d'Herbomez M, Do Cao C, Vezzosi D, Borzon-Chasot F, Baudin E; groupe des tumeurs endocrines (GTE France). d'Herbomez M, et al. Among authors: do cao c. Ann Endocrinol (Paris). 2010 Sep;71(4):274-80. doi: 10.1016/j.ando.2010.04.004. Epub 2010 Jun 9. Ann Endocrinol (Paris). 2010. PMID: 20538257 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters